Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China

Lipids

Volumn 47, Issue 6, 2012, Pages 549-556

  Zheng, Ju Sheng ^a,b   Xu, Amei ^a,b   Huang, Tao ^a,b   Yu, Xiaomei ^c   Li, Duo ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b APCNS Centre of Nutrition and Food Safety   (China)

^c ZHEJIANG HOSPITAL   (China)

Author keywords

Dihomo gamma linolenic acid; Docosahexaenoic acid; Non alcoholic fatty liver disease; Saturated fatty acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN GLUCURONIDE; CREATININE; DOCOSAHEXAENOIC ACID; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; SATURATED FATTY ACID; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHINA; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PATIENT ASSESSMENT; PHOSPHOLIPID BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; ALANINE TRANSAMINASE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHINA; CHOLESTEROL, HDL; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS; FATTY LIVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHOSPHOLIPIDS; PREVALENCE; RISK FACTORS;

EID: 84863430608     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-012-3671-4     Document Type: Article

References (43)

1. Angulo P (2007) GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 25:883-889
2. Fan JG, Farrell GC (2009) Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 50:204-210
3. Farrell GC, Chitturi S, Lau GK, Sollano JD (2007) Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 22:775-777 (Pubitemid 46911045)
4. Riquelme A, Arrese M, Soza A, Morales A, Baudrand R, Perez-Ayuso RM, Gonzalez R, Alvarez M, Hernandez V, Garcia-Zattera MJ, Otarola F, Medina B, Rigotti A, Miquel JF, Marshall G, Nervi F (2009) Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int 29:82-88
5. Goessling W, Massaro JM, Vasan RS, D'Agostino RB Sr, Ellison RC, Fox CS (2008) Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 135:1935-1944
6. Targher G (2007) Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 24:1-6 (Pubitemid 46103064)
7. Fan JG, Zhu JN, Li XJ, Chen L, Lu YS, Li L, Dai F, Li F, Chen SY (2005) Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 20:1825-1832 (Pubitemid 43961036)
8. Sathiaraj E, Chutke M, Reddy MY, Pratap N, Rao PN, Reddy DN, Raghunath M (2011) A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population. Eur J Clin Nutr 65:533-537
9. Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A (2007) What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol 22:794-800 (Pubitemid 46911036)
10. Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL (2007) How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 22:788-793 (Pubitemid 46911047)
11. Sessler AM, Ntambi JM (1998) Polyunsaturated fatty acid regulation of gene expression. J Nutr 128:923-926 (Pubitemid 28280188)
12. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, Faga E, Silli B, Pagano G (2003) Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 37:909-916 (Pubitemid 36397404)
13. Zelber-Sagil S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z, Oren R (2007) Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study. J Hepatol 47:711-717 (Pubitemid 47503432)
14. Oya J, Nakagami T, Sasaki S, Jimba S, Murakami K, Kasahara T, Wasada T, Sekiguchi H, Hasegawa M, Endo Y, Iwamoto Y (2010) Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women. Eur J Clin Nutr 64:1179-1185
15. Spadaro L, Magliocco O, Spampinato D, Piro S, Oliveri C, Alagona C, Papa G, Rabuazzo AM, Purrello F (2008) Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis 40:194-199 (Pubitemid 351181793)
16. Sofi F, Giangrandi I, Cesari F, Corsani I, Abbate R, Gensini GF, Casini A (2010) Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study. Int J Food Sci Nutr 61:792-802
17. Huang T, Wahlqvist ML, Xu TC, Xu A, Zhang AZ, Li D (2010) Increased plasma n-3 polyunsaturated fatty acid is associated with improved insulin sensitivity in type 2 diabetes in China. Mol Nutr Food Res 54:S112-S119
18. Huang T, Bhulaidok S, Cai ZZ, Xu TC, Xu F, Wahlqvist ML, Li D (2010) Plasma phospholipids n-3 polyunsaturated fatty acid is associated with metabolic syndrome. Mol Nutr Food Res 54:1628-1635
19. Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37:1202-1219 (Pubitemid 36538699)
20. Sinclair AJ, O'Dea K, Dunstan G, Ireland PD, Niall M (1987) Effects on plasma lipids and fatty acid composition of very low fat diets enriched with fish or kangaroo meat. Lipids 22:523-529
21. Riboli E, Ronnholm H, Saracci R (1987) Biological Markers of Diet. Cancer Surv 6:685-718
22. Hunter D (1995) Biochemical indicators of dietary intake. In: Willett WC (ed) Nutritional epidemiology, Oxford University Press, New York, np 143-203
23. Larter CZ, Yeh MM, Van Rooyen DM, Teoh NC, Brooling J, Hou JY, Williams J, Clyne M, Nolan CJ, Farrell GC (2009) Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice. J Gastroenterol Hepatol 24:1658-1668
24. Woollett LA, Spady DK, Dietschy JM (1992) Regulatory effects of the saturated fatty-acids 6-0 through 18-0 on hepatic lowdensitylipoprotein receptor activity in the Hamster. J Clin Invest 89:1133-1141
25. Spady DK, Woollett LA, Dietschy JM (1993) Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. Annu Rev Nutr 13:355-381 (Pubitemid 23227789)
26. Vallim T, Salter AM (2010) Regulation of hepatic gene expression by saturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 82:211-218
27. Yoshikawa T, Shimano H, Yahagi N, Ide T, Amemiya-Kudo M, Matsuzaka T, Nakakuki M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Takahashi A, Sone H, Osuga Ji J, Gotoda T, Ishibashi S, Yamada N (2002) Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 277:1705-1711 (Pubitemid 34968740)
28. Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM, Jalali P, Kandasamy T, Prayitno N, Sherman M, Guindi M, Ma DW, Heathcote JE (2008) Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J Hepatol 48:300-307
29. Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T (2008) Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 42:413-418 (Pubitemid 351450629)
30. Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, Poniachik J (2004) Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci 106:635-643 (Pubitemid 38797577)
31. Fan JG, Peng YD (2007) Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat Dis Int 6:572-578
32. Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, Contos MJ, Sterling RK, Fuchs M, Zhou H, Watkins SM, Sanyal AJ (2009) The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 50:1827-1838
33. Fu CC, Chen MC, Li YM, Liu TT, Wang LY (2009) The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents. Ann Acad Med Singap 38:15-21
34. Cardoso C R L, Leite NC, Salles GF, Araujo A L E, Villela-Nogueira CA (2009) Prevalence and associated factors of nonalcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int 29:113-119
35. Ruhl CE, Everhart JE (2003) Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124:71-79 (Pubitemid 36055340)
36. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R (2006) Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 26:856-863 (Pubitemid 44165254)
37. Kim BK, Han KH, Ahn SH (2011) "Normal" range of alanine aminotransferase levels for Asian population. J Gastroenterol Hepatol 26:219-220
38. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults-findings fromthe third national health and nutrition examination survey. JAMA 287:356-359 (Pubitemid 34251969)
39. Nestel P, Lyu R, Low LP, Sheu WH, Nitiyanant W, Saito I, Tan CE (2007) Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr 16:362-367 (Pubitemid 46750768)
40. Li Y, Xu C, Yu C, Xu L, Miao M (2009) Association of serum uric acid level with non-alcoholic fatty liver disease: a crosssectional study. J Hepatol 50:1029-1034
41. Bajaj S, Nigam P, Luthra A, Pandey RM, Kondal D, Bhatt SP, Wasir JS, Misra A (2009) A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease. Indian J Med Res 129:285-292
42. Uchil D, Pipalia D, Chawla M, Patel R, Maniar S, Narayani, Juneja A (2009) Non-alcoholic fatty liver disease (NAFLD)-the hepatic component of metabolic syndrome. J Assoc Physicians India 57:201-204
43. Ma J, Folsom AR, Shahar E, Eckfeldt JH (1995) Plasma fattyacid composition as an indicator of habitual dietary-fat intake in middle-aged adults. Am J Clin Nutr 62:564-571